These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22922344)

  • 1. Immunosuppressant discovery from Tripterygium wilfordii Hook f: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8).
    Tang W; Zuo JP
    Acta Pharmacol Sin; 2012 Sep; 33(9):1112-8. PubMed ID: 22922344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii.
    Ma J; Dey M; Yang H; Poulev A; Pouleva R; Dorn R; Lipsky PE; Kennelly EJ; Raskin I
    Phytochemistry; 2007 Apr; 68(8):1172-8. PubMed ID: 17399748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f.
    Qiu D; Kao PN
    Drugs R D; 2003; 4(1):1-18. PubMed ID: 12568630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in the study of immunopharmacological effects and mechanisms of extracts of Tripterygium wilfordii Hook. f. in neuroimmunologic disorders].
    Pan XD; Chen XC
    Yao Xue Xue Bao; 2008 Dec; 43(12):1179-85. PubMed ID: 19244746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide: progress on research in pharmacodynamics and toxicology.
    Li XJ; Jiang ZZ; Zhang LY
    J Ethnopharmacol; 2014 Aug; 155(1):67-79. PubMed ID: 24933225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F.
    Chen BJ
    Leuk Lymphoma; 2001 Jul; 42(3):253-65. PubMed ID: 11699390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects.
    Song CY; Xu YG; Lu YQ
    J Zhejiang Univ Sci B; 2020 Apr.; 21(4):280-290. PubMed ID: 32253838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulatory effects of Tripterygium wilfordii Hook F and its extracts in clinical practice.
    Luo D; Zuo Z; Zhao H; Tan Y; Xiao C
    Front Med; 2019 Oct; 13(5):556-563. PubMed ID: 30604167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide: reflections on two decades of research and prospects for the future.
    Tong L; Zhao Q; Datan E; Lin GQ; Minn I; Pomper MG; Yu B; Romo D; He QL; Liu JO
    Nat Prod Rep; 2021 Apr; 38(4):843-860. PubMed ID: 33146205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress of effect and mechanisms of Tripterygium wilfordii on immune system].
    Nong C; Wang XZ; Jiang ZZ; Zhang LY
    Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3374-3383. PubMed ID: 31602898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pharmacological Effects and Mechanism of Tripterygium wilfordii Hook F in Central Nervous System Autoimmunity.
    Wang Q; Meng J; Dong A; Yu JZ; Zhang GX; Ma CG
    J Altern Complement Med; 2016 Jul; 22(7):496-502. PubMed ID: 27224044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae).
    Brinker AM; Ma J; Lipsky PE; Raskin I
    Phytochemistry; 2007 Mar; 68(6):732-66. PubMed ID: 17250858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases.
    Han R; Rostami-Yazdi M; Gerdes S; Mrowietz U
    Br J Clin Pharmacol; 2012 Sep; 74(3):424-36. PubMed ID: 22348323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in research on mechanisms of anti-rheumatoid arthritis of triptolide].
    Liu CF; Lin N
    Zhongguo Zhong Yao Za Zhi; 2006 Oct; 31(19):1575-9. PubMed ID: 17165577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
    Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP
    Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [16-Hydroxytriptolide, a new active diterpene isolated from Tripterygium wilford II].
    Ma PC; Lu XY; Yang JJ; Zheng QT
    Yao Xue Xue Bao; 1991; 26(10):759-63. PubMed ID: 1823717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide and its expanding multiple pharmacological functions.
    Liu Q
    Int Immunopharmacol; 2011 Mar; 11(3):377-83. PubMed ID: 21255694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F.
    Tao X; Cai JJ; Lipsky PE
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1305-12. PubMed ID: 7891348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemical characterization of the functional constituents of Tripterygium wilfordii contributing to its anti-inflammatory property.
    Wong KF; Chan JK; Chan KL; Tam P; Yang D; Fan ST; Luk JM
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):55-9. PubMed ID: 18047628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production.
    Tao X; Schulze-Koops H; Ma L; Cai J; Mao Y; Lipsky PE
    Arthritis Rheum; 1998 Jan; 41(1):130-8. PubMed ID: 9433878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.